Amber J Wiseman, PA-C in Mcintosh, SD - Physician Assistant

Amber J Wiseman, PA-C is a Physician Assistant based in Mcintosh, South Dakota. Amber J Wiseman is licensed to practice in South Dakota (license number 0656) and her current practice location is 208 Main Street, Mcintosh, South Dakota. She can be reached at her office (for appointments etc.) via phone at (605) 273-4335.

NPI number for Amber J Wiseman is 1952346678 and her current mailing address is Po Box 195, Mc Intosh, South Dakota. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1952346678.

Contact Information

	Amber J Wiseman, PA-C
	208 Main Street, Mcintosh, SD 57641-0195
	(605) 273-4335
	(605) 273-4360

Provider's Profile

Full Name	Amber J Wiseman
Gender	Female
Speciality	Physician Assistant
Location	208 Main Street, Mcintosh, South Dakota
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1952346678
Provider Enumeration Date: 06/17/2006
Last Update Date: 02/14/2012

Medical Identifiers

Medical identifiers for Amber J Wiseman such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1952346678	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
363A00000X	Physician Assistant	0656 (South Dakota)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Amber J Wiseman is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Amber J Wiseman, PA-C Po Box 195, Mc Intosh, SD 57641-0195 Ph: (605) 273-4335	Amber J Wiseman, PA-C 208 Main Street, Mcintosh, SD 57641-0195 Ph: (605) 273-4335

News Archive

House Democrats meet, weigh reform's reconciliation option

The Wall Street Journal / Dow Jones reports on a meeting of House Democrats on the health overhaul Tuesday night. Some Democrats have suggested that the House adopt the bill passed by the Senate in December and then have the House and Senate modify that bill through a cumbersome budget process called reconciliation. Rep. James Clyburn, D-S.C., said earlier in the day that he was confident Democrats could pass a health overhaul that way. But other members are reluctant.

New stem cell treatment may halt clinical relapses, development of new brain lesions in patients MS

A new use of chemotherapy followed by autologous haematopoietic stem cell transplantation (aHSCT) has fully halted clinical relapses and development of new brain lesions in 23 of 24 patients with multiple sclerosis (MS) for a prolonged period without the need for ongoing medication, according to a new phase 2 clinical trial, published in The Lancet.

USPTO issues patent related to Seattle Genetics' ADC technology

Seattle Genetics, Inc. announced today that the U.S. Patent and Trademark Office has issued a patent related to its antibody-drug conjugate (ADC) technology. U.S. Patent No. 7,659,241 covers cleavable linkers and potent auristatin drug payloads used in certain of Seattle Genetics' ADC programs, most notably brentuximab vedotin (SGN-35), as well as many ADC programs in development by its collaborators.

Encouraging results from Alexion's eculizumab Phase 2 study on generalized myasthenia gravis

Alexion Pharmaceuticals, Inc. today announced that the Company's study of eculizumab in a small group of 14 patients with severe and refractory generalized myasthenia gravis, an ultra-rare and debilitating form of generalized myasthenia gravis (gMG), showed a strong disease improvement signal.

Amber J Wiseman, PA-C - Physician Assistant in Mcintosh, SD